Login / Signup

Long-term efficacy and safety of romiplostim in refractory aplastic anemia: follow-up of a phase 2/3 study.

Kinuko MitaniJong Wook LeeJun Ho JangYoshiaki TomiyamaKoji MiyazakiKoji NagafujiKensuke UsukiNobuhiko UoshimaTomoaki FujisakiHiroshi KosugiItaru MatsumuraKo SasakiMasahiro KizakiMasashi SawaMichihiro HidakaNaoki KobayashiSatoshi IchikawaYuji YonemuraKenta MurotaniMami ShimizuAkira MatsudaKeiya OzawaShinji Nakao
Published in: Blood advances (2024)
Keyphrases
  • chronic kidney disease
  • open label
  • allogeneic hematopoietic stem cell transplantation
  • iron deficiency
  • placebo controlled
  • clinical trial